DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Zinman B, Wanner C, Lachin JM. et al.
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.
N Engl J Med 2015;
373: 2117-2128.
DOI: 10.1056/NEJMoa1504720.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.